Arbidol HCl Inhibits PRRSV Infection by Downregulating CD163 and MYH9 Expression and Modulating Inflammatory Responses
Transboundary and Emerging Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/tbed/2505057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 31.10.2026. Verfasst von Li Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Agriculture and Biology, Liaocheng University, Liaocheng, China, lcu.edu.cn. Hauptthemen laut MEDLINE: Porcine respiratory and reproductive syndrome virus, Indoles, Antiviral Agents, Antigens, Differentiation, Myelomonocytic. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Shandong Provincial Agricultural Major Technology Collaborative Promotion Program, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Porcine reproductive and respiratory syndrome (PRRS) constitutes a major challenge for global pig production, yet effective therapeutic interventions remain elusive. Our study investigated the antiviral potency of Arbidol HCl in counteracting PRRSV infection through comprehensive in permissive cells and in vivo approaches. Our observations demonstrate that Arbidol HCl confers an obvious antiviral activity against varied PRRSV isolates in MARC‐145 cells and primary porcine alveolar macrophages (PAMs). Mechanistic studies revealed that Arbidol HCl inhibits the early stages of PRRSV infection by significantly downregulating the expression of key viral receptors cysteine‐rich scavenger receptor (CD163) and myosin heavy chain 9 (MYH9), thereby disrupting viral attachment and internalization. Subsequent validation studies indicated that Arbidol HCl attenuates proinflammatory responses caused by PRRSV via suppressing the toll‐like receptor 4 (TLR4)/nuclear factor kappa B (NF‐κB) signaling pathway. In vivo experiments using PRRSV‐infected piglets demonstrated that Arbidol HCl treatment significantly reduced viral loads in serum, alleviated lung pathological damage, and mitigated systemic inflammatory responses. These results collectively establish Arbidol HCl as a promising dual‐action therapeutic agent that combines direct antiviral effects with anti‐inflammatory properties. Our study offers hope for developing a practical therapeutic intervention that could significantly impact swine health and food security worldwide. It will provide a novel approach for PRRS prevention and treatment in swine production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Agriculture and Biology, Liaocheng University, Liaocheng, China, lcu.edu.cn.
- Shandong Provincial General Station of Animal Husbandry, Jinan, 250100, China.
- College of Animal Science and Technology, Shandong Agricultural University, Tai'an, China, sdau.edu.cn.
- Key Laboratory of Livestock and Poultry Multi-Omics of MARA, Institute of Animal Science and Veterinary Medicine, Shandong Academy of Agricultural Sciences, Jinan, 250100, China, saas.ac.cn.
ORCID-Profile: Yubao Li, Yuyu Zhang, Muhammad Zahoor Khan, Jiaqiang Wu, Tongtong Wang
Förderung
- China Postdoctoral Science Foundation
- Shandong Provincial Agricultural Major Technology Collaborative Promotion Program
- Natural Science Foundation of Shandong Province
- Shandong Province Pig Industrial Technology System
- Youth Project of Shandong Province Higher Educational Science and Technology Program
Zitieren
APA
Chen, L., Gao, M., Zhan, X., Kong, L., Jiang, S., Shang, S., Li, E. X., Peng, X., Dai, Q., Li, Y., Zhang, Y., Khan, M. Z., Li, L., Wu, J., & Wang, T. (2026). Arbidol HCl Inhibits PRRSV Infection by Downregulating CD163 and MYH9 Expression and Modulating Inflammatory Responses. Transboundary and Emerging Diseases, 2026(1). https://doi.org/10.1155/tbed/2505057
Vancouver
Chen L, Gao M, Zhan X, Kong L, Jiang S, Shang S, et al. Arbidol HCl Inhibits PRRSV Infection by Downregulating CD163 and MYH9 Expression and Modulating Inflammatory Responses. Transboundary and Emerging Diseases. 2026;2026(1). doi:10.1155/tbed/2505057
BibTeX
@article{Chen2026,
author = {Chen, Li and Gao, Mengxue and Zhan, Xiaoyang and Kong, Lei and Jiang, Shuzhen and Shang, Suimin and Li, En-Xin and Peng, Xiaoting and Dai, Qiuju and Li, Yubao and Zhang, Yuyu and Khan, Muhammad Zahoor and Li, Liangliang and Wu, Jiaqiang and Wang, Tongtong},
title = {Arbidol HCl Inhibits PRRSV Infection by Downregulating CD163 and MYH9 Expression and Modulating Inflammatory Responses},
journal = {Transboundary and Emerging Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/tbed/2505057}
}
EUVIMED